FOI release

Freedom of Information request on how suspected reactions reported in association with available COVID-19 vaccines are published (FOI 21/474)

Published 28 June 2021

24th May 2021 FOI 21/474

Dear

Thank you for your email. We intend to publish all suspected reactions reported in association with available COVID-19 vaccines in an interactive format as iDAPs, along with our ADR summary that is published each week. The use of iDAPs will enable users to view the data by categories of their choice such as age, sex and seriousness of reports. Users will also be able to download the data tables in CSV format. We would be happy to provide you with a link to this when it is published.

Kind regards,

FOI Team Vigilance and Risk Management of Medicines Division Medicines and Healthcare Products Regulatory Agency 10 South Colonnade, Canary Wharf, London E14 4PU